 |
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
The solution nmr structure of the n-terminal protease domain of the hepatitis c virus (hcv) ns3-protein, from bk strain, 20 structures
|
|
Structure:
|
 |
Ns3 serine protease. Chain: a. Engineered: yes. Mutation: yes. Other_details: compound engineered adding a solubilising tail at thE C-terminus
|
|
Source:
|
 |
Hepatitis c virus. Organism_taxid: 11103. Strain: bk. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
|
|
NMR struc:
|
 |
20 models
|
 |
|
Authors:
|
 |
G.Barbato,D.O.Cicero,M.C.Nardi,C.Steinkuhler,R.Cortese,R.De Francesco,R.Bazzo
|
Key ref:
|
 |
G.Barbato
et al.
(1999).
The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism.
J Mol Biol,
289,
371-384.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
01-Sep-98
|
Release date:
|
22-Jun-99
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P26663
(POLG_HCVBK) -
Genome polyprotein
|
|
|
|
Seq: Struc:
|
 |
 |
 |
3010 a.a.
165 a.a.*
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 10 residue positions (black
crosses)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
E.C.2.7.7.48
- RNA-directed Rna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1)
|
 |
 |
 |
 |
 |
Nucleoside triphosphate
|
+
|
RNA(n)
|
=
|
diphosphate
|
+
|
RNA(n+1)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.3.4.21.98
- Hepacivirin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Hydrolysis of four peptide bonds in the viral precursor polyprotein, commonly with Asp or Glu in the P6 position, Cys or Thr in P1 and Ser or Ala in P1'.
|
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
E.C.3.6.1.15
- Nucleoside-triphosphatase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
NTP + H2O = NDP + phosphate
|
 |
 |
 |
 |
 |
NTP
|
+
|
H(2)O
|
=
|
NDP
|
+
|
phosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
E.C.3.6.4.13
- Rna helicase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + H2O = ADP + phosphate
|
 |
 |
 |
 |
 |
ATP
|
+
|
H(2)O
|
=
|
ADP
|
+
|
phosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
transformation of host cell by virus
|
2 terms
|
 |
|
Biochemical function
|
catalytic activity
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Mol Biol
289:371-384
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism.
|
|
G.Barbato,
D.O.Cicero,
M.C.Nardi,
C.Steinkühler,
R.Cortese,
R.De Francesco,
R.Bazzo.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The solution structure of the hepatitis C virus (BK strain) NS3 protein
N-terminal domain (186 residues) has been solved by NMR spectroscopy. The
protein is a serine protease with a chymotrypsin-type fold, and is involved in
the maturation of the viral polyprotein. Despite the knowledge that its activity
is enhanced by the action of a viral protein cofactor, NS4A, the mechanism of
activation is not yet clear. The analysis of the folding in solution and the
differences from the crystallographic structures allow the formulation of a
model in which, in addition to the NS4A cofactor, the substrate plays an
important role in the activation of the catalytic mechanism. A unique structural
feature is the presence of a zinc-binding site exposed on the surface, subject
to a slow conformational exchange process.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. A stereoview of the 20 minimum-energy structures is
shown. For the overlay, the SCR residues identifying the
β-strands plus the helicoidal segments were used. Due to its
peculiar mobility, see the NS4a interaction section, strand D1
was omitted in the calculation of the r.m.s.d. The first 21
residues were not included in the structure calculation, because
for them no structural information was available.
|
 |
Figure 7.
Figure 7. Zoomed view of the substrate interaction region.
The S′ and S regions range approximately from strand A1
(identified by the position of T38) to loop E2-F2 (G162),
encompassing the rather flat surface defined by the E2 strand
(F154 bottom of recognition pocket, A157 H-bond candidate with
substrate P3 partner) on one side and the α2 helix (oxyanion
hole G137-S139; L135 delimiting the top side of the recognition
pocket) on the other side.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(1999,
289,
371-384)
copyright 1999.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Geitmann,
G.Dahl,
and
U.H.Danielson
(2011).
Mechanistic and kinetic characterization of hepatitis C virus NS3 protein interactions with NS4A and protease inhibitors.
|
| |
J Mol Recognit, 24,
60-70.
|
 |
|
|
|
|
 |
A.Peres-da-Silva,
A.J.de Almeida,
and
E.Lampe
(2010).
Mutations in hepatitis C virus NS3 protease domain associated with resistance to specific protease inhibitors in antiviral therapy naïve patients.
|
| |
Arch Virol, 155,
807-811.
|
 |
|
|
|
|
 |
Y.Zhou,
W.P.Tzeng,
Y.Ye,
Y.Huang,
S.Li,
Y.Chen,
T.K.Frey,
and
J.J.Yang
(2009).
A cysteine-rich metal-binding domain from rubella virus non-structural protein is essential for viral protease activity and virus replication.
|
| |
Biochem J, 417,
477-483.
|
 |
|
|
|
|
 |
C.Welsch,
F.S.Domingues,
S.Susser,
I.Antes,
C.Hartmann,
G.Mayr,
A.Schlicker,
C.Sarrazin,
M.Albrecht,
S.Zeuzem,
and
T.Lengauer
(2008).
Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of the hepatitis C virus.
|
| |
Genome Biol, 9,
R16.
|
 |
|
|
|
|
 |
V.Brass,
J.M.Berke,
R.Montserret,
H.E.Blum,
F.Penin,
and
D.Moradpour
(2008).
Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex.
|
| |
Proc Natl Acad Sci U S A, 105,
14545-14550.
|
 |
|
|
|
|
 |
W.Yang,
Y.Zhao,
J.Fabrycki,
X.Hou,
X.Nie,
A.Sanchez,
A.Phadke,
M.Deshpande,
A.Agarwal,
and
M.Huang
(2008).
Selection of replicon variants resistant to ACH-806, a novel hepatitis C virus inhibitor with no cross-resistance to NS3 protease and NS5B polymerase inhibitors.
|
| |
Antimicrob Agents Chemother, 52,
2043-2052.
|
 |
|
|
|
|
 |
C.Oliva,
A.Rodríguez,
M.González,
and
W.Yang
(2007).
A quantum mechanics/molecular mechanics study of the reaction mechanism of the hepatitis C virus NS3 protease with the NS5A/5B substrate.
|
| |
Proteins, 66,
444-455.
|
 |
|
|
|
|
 |
R.De Francesco,
and
A.Carfí
(2007).
Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus.
|
| |
Adv Drug Deliv Rev, 59,
1242-1262.
|
 |
|
|
|
|
 |
S.Melino,
and
M.Paci
(2007).
Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach.
|
| |
FEBS J, 274,
2986-3002.
|
 |
|
|
|
|
 |
T.Suzuki,
H.Aizaki,
K.Murakami,
I.Shoji,
and
T.Wakita
(2007).
Molecular biology of hepatitis C virus.
|
| |
J Gastroenterol, 42,
411-423.
|
 |
|
|
|
|
 |
H.Zhou,
N.J.Singh,
and
K.S.Kim
(2006).
Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor.
|
| |
Proteins, 65,
692-701.
|
 |
|
|
|
|
 |
N.J.Baxter,
A.Roetzer,
H.D.Liebig,
S.E.Sedelnikova,
A.M.Hounslow,
T.Skern,
and
J.P.Waltho
(2006).
Structure and dynamics of coxsackievirus B4 2A proteinase, an enyzme involved in the etiology of heart disease.
|
| |
J Virol, 80,
1451-1462.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Melino,
S.Fucito,
A.Campagna,
F.Wrubl,
A.Gamarnik,
D.O.Cicero,
and
M.Paci
(2006).
The active essential CFNS3d protein complex.
|
| |
FEBS J, 273,
3650-3662.
|
 |
|
|
|
|
 |
U.C.Chaturvedi,
and
R.Shrivastava
(2005).
Interaction of viral proteins with metal ions: role in maintaining the structure and functions of viruses.
|
| |
FEMS Immunol Med Microbiol, 43,
105-114.
|
 |
|
|
|
|
 |
L.Lu,
T.J.Pilot-Matias,
K.D.Stewart,
J.T.Randolph,
R.Pithawalla,
W.He,
P.P.Huang,
L.L.Klein,
H.Mo,
and
A.Molla
(2004).
Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitro.
|
| |
Antimicrob Agents Chemother, 48,
2260-2266.
|
 |
|
|
|
|
 |
M.J.Richer,
L.Juliano,
C.Hashimoto,
and
F.Jean
(2004).
Serpin mechanism of hepatitis C virus nonstructural 3 (NS3) protease inhibition: induced fit as a mechanism for narrow specificity.
|
| |
J Biol Chem, 279,
10222-10227.
|
 |
|
|
|
|
 |
M.Shokhen,
and
A.Albeck
(2004).
Identification of protons position in acid-base enzyme catalyzed reactions: the hepatitis C viral NS3 protease.
|
| |
Proteins, 55,
245-250.
|
 |
|
|
|
|
 |
P.Niyomrattanakit,
P.Winoyanuwattikun,
S.Chanprapaph,
C.Angsuthanasombat,
S.Panyim,
and
G.Katzenmeier
(2004).
Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation.
|
| |
J Virol, 78,
13708-13716.
|
 |
|
|
|
|
 |
A.Pause,
G.Kukolj,
M.Bailey,
M.Brault,
F.Dô,
T.Halmos,
L.Lagacé,
R.Maurice,
M.Marquis,
G.McKercher,
C.Pellerin,
L.Pilote,
D.Thibeault,
and
D.Lamarre
(2003).
An NS3 serine protease inhibitor abrogates replication of subgenomic hepatitis C virus RNA.
|
| |
J Biol Chem, 278,
20374-20380.
|
 |
|
|
|
|
 |
C.Trozzi,
L.Bartholomew,
A.Ceccacci,
G.Biasiol,
L.Pacini,
S.Altamura,
F.Narjes,
E.Muraglia,
G.Paonessa,
U.Koch,
R.De Francesco,
C.Steinkuhler,
and
G.Migliaccio
(2003).
In vitro selection and characterization of hepatitis C virus serine protease variants resistant to an active-site peptide inhibitor.
|
| |
J Virol, 77,
3669-3679.
|
 |
|
|
|
|
 |
F.Narjes,
U.Koch,
and
C.Steinkühler
(2003).
Recent developments in the discovery of hepatitis C virus serine protease inhibitors--towards a new class of antiviral agents?
|
| |
Expert Opin Investig Drugs, 12,
153-163.
|
 |
|
|
|
|
 |
M.P.Walker,
N.Yao,
and
Z.Hong
(2003).
Promising candidates for the treatment of chronic hepatitis C.
|
| |
Expert Opin Investig Drugs, 12,
1269-1280.
|
 |
|
|
|
|
 |
A.Casbarra,
F.D.Piaz,
P.Ingallinella,
S.Orrù,
P.Pucci,
A.Pessi,
and
E.Bianchi
(2002).
The effect of prime-site occupancy on the hepatitis C virus NS3 protease structure.
|
| |
Protein Sci, 11,
2102-2112.
|
 |
|
|
|
|
 |
S.J.Archer,
D.M.Camac,
Z.J.Wu,
N.A.Farrow,
P.J.Domaille,
Z.R.Wasserman,
M.Bukhtiyarova,
C.Rizzo,
S.Jagannathan,
L.J.Mersinger,
and
C.A.Kettner
(2002).
Hepatitis C virus NS3 protease requires its NS4A cofactor peptide for optimal binding of a boronic acid inhibitor as shown by NMR.
|
| |
Chem Biol, 9,
79-92.
|
 |
|
|
|
|
 |
B.W.Dymock
(2001).
Emerging therapies for hepatitis C virus infection.
|
| |
Expert Opin Emerg Drugs, 6,
13-42.
|
 |
|
|
|
|
 |
U.Koch,
G.Biasiol,
M.Brunetti,
D.Fattori,
M.Pallaoro,
and
C.Steinkühler
(2001).
Role of charged residues in the catalytic mechanism of hepatitis C virus NS3 protease: electrostatic precollision guidance and transition-state stabilization.
|
| |
Biochemistry, 40,
631-640.
|
 |
|
|
|
|
 |
D.Fattori,
A.Urbani,
M.Brunetti,
R.Ingenito,
A.Pessi,
K.Prendergast,
F.Narjes,
V.G.Matassa,
R.De Francesco,
and
C.Steinkühler
(2000).
Probing the active site of the hepatitis C virus serine protease by fluorescence resonance energy transfer.
|
| |
J Biol Chem, 275,
15106-15113.
|
 |
|
|
|
|
 |
F.Narjes,
M.Brunetti,
S.Colarusso,
B.Gerlach,
U.Koch,
G.Biasiol,
D.Fattori,
R.De Francesco,
V.G.Matassa,
and
C.Steinkühler
(2000).
Alpha-ketoacids are potent slow binding inhibitors of the hepatitis C virus NS3 protease.
|
| |
Biochemistry, 39,
1849-1861.
|
 |
|
|
|
|
 |
S.Di Marco,
M.Rizzi,
C.Volpari,
M.A.Walsh,
F.Narjes,
S.Colarusso,
R.De Francesco,
V.G.Matassa,
and
M.Sollazzo
(2000).
Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexes.
|
| |
J Biol Chem, 275,
7152-7157.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.Ueno,
S.Misawa,
Y.Ohba,
M.Matsumoto,
M.Mizunuma,
N.Kasai,
K.Tsumoto,
I.Kumagai,
and
H.Hayashi
(2000).
Isolation and characterization of monoclonal antibodies that inhibit hepatitis C virus NS3 protease.
|
| |
J Virol, 74,
6300-6308.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|